Concepedia

Publication | Open Access

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

DOIFull Paper Access

242

Citations

24

References

2017

Year

Heidi Taipale, Ellenor Mittendorfer‐Rutz, Kristina Alexanderson, Maila Majak, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon,
Schizophrenia Research

Abstract

Among patients with schizophrenia, LAI use is associated with an approximately 30% lower risk of death compared with oral agents. SG LAIs and oral aripiprazole are associated with the lowest mortality.

References

YearCitations

Page 1